N
LFMD icon

Natixis’s LifeMD LFMD Stock Holding History

Natixis’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-215,300
Closed -$2.93M – 1153
2025
Q2 		$2.93M Buy
+215,300
New +$2.03M 0.01% 427

Other funds holding LFMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Natixis's LFMD Position: Q3 2025 in Review

Natixis sold out of LifeMD (LFMD) in Q3 2025, closing a stake of 215,300 shares — an estimated $2.93M sold.

Natixis first reported a position in LFMD in Q2 2025 and held it in 1 quarter. The position peaked at $2.93M in Q2 2025. 114 funds tracked by Wall St. Rank hold LFMD as of Q3 2025.

  • Natixis reported no remaining LifeMD position as of Q3 2025 after selling out during the quarter.
  • Natixis sold 215,300 LifeMD shares in Q3 2025, an estimated $2.93M.
  • Natixis first reported a position in LifeMD in Q2 2025 and held it in 1 quarter.
  • Natixis's LifeMD position peaked at $2.93M in Q2 2025.
  • 114 funds tracked by Wall St. Rank held LifeMD as of Q3 2025.

Based on Natixis's 13F filing for Q3 2025, filed 14 Nov 2025.